IBM Jumps 12% on a $1 Billion CHIPS Act Quantum Foundry Award - Is IBM Stock a Buy at $253?

TradingKey - IBM surged 12.4% on a proposed $1B CHIPS Act quantum foundry award targeting fault-tolerant quantum by 2029. Q1 EPS $1.91 beat, Red Hat AI services launched. Trendline breakout. Target $263–$277.

On May 22, IBM (IBM) rallied 12.43% to $252.97 following news that the Department of Commerce has put forth an award for a CHIPS Act project funding a $1 billion quantum foundry for the United States with the participation of IBM as the leading company. With this award, IBM has been nominated as the nation's leader in quantum infrastructure, which in turn provides a floor of government demand to a sector of business that has steadily built toward the realization of fault-tolerant quantum computing by 2029.

On a daily chart, IBM has decisively broken above a descending trend line connecting February highs around $263 to $272, surpassing the 1.272 Fibonacci extension at $237.23 in a spike of volume with the RSI at 65.59. The breakout is clean. Can this quantum announcement be merely a single-day catalyst, or the beginning of a re-rating?

The $1 Billion CHIPS Act Quantum Foundry: What it Is and Why it Matters

The $1 billion CHIPS Act proposed award is not a research grant; this is infrastructure spending to build a purpose-built quantum foundry in the U.S. The IBM quantum roadmap plans to deploy large scale, fault-tolerant quantum computers by 2029, with the foundry supplying the required manufacturing capacity for the specialized chipsets and components needed to power fault-tolerant quantum computing in a way that would be far beyond what a laboratory could ever produce.

Fault-tolerant quantum, meaning quantum in which errors are corrected in real-time and operations can be run in a reliable way at scale, is the inflection point that changes quantum computing from a research project to a commercially usable platform for drug discovery, materials science, financial modeling, and cryptography.

The global strategic significance of a U.S. quantum foundry is similar to the significance of a CHIPS Act chip foundry: it's the government saying quantum computing is a critical technology that the U.S. has to be able to manufacture domestically.

There is only one U.S. company in a position to lead this initiative: one that has both the technical roadmap and the infrastructure in place to make that happen, the IBM quantum initiative. IBM quantum computers already have paying customers—a milestone was struck recently with a use case simulating proteins to be used for health care and drug research—while the foundry will advance the time when these applications can be delivered in meaningful volumes.

Q1 2026 Earnings and Red Hat AI: What the Business Looks Like Behind the Quantum Headline

IBM released its earnings report for Q1 2026 on April 22, offering fundamental perspective into why the quantum announcement has landed on a strong footing. IBM posted revenues for Q1 2026 of $15.92 billion, which was a 9% year-over-year growth rate, and software, at 11% and infrastructure, at 15% respectively, both also posted growth rates. Adjusted EPS came to $1.91, above expectations of $1.81.

Free cash flow grew by 13% year-over-year to $2.2 billion. The company reaffirmed its annual outlook for constant-currency revenues in excess of 5% and a free cash flow improvement in the $1 billion range. These aren't the kinds of growth numbers you would typically see from an AI supercycle, but they're sufficiently steady and cash-producing to sustain both the dividend and investment in the quantum business.

Red Hat, a hybrid cloud technology acquired by IBM in 2019, continues to accrue earnings. IBM introduced a pair of new managed services on May 12: Red Hat AI Inference on IBM Cloud and Red Hat OpenShift Virtualization Service on IBM Cloud, which are tailored to highly regulated business sectors, such as financial services, health care, and government, which require AI workloads that work within hybrid clouds and have security, compliance, and sovereignty baked in.

IBM's partnerships for governance AI and watsonx are also designed for the same end user: this is the enterprise AI vertical not yet fully addressed by Nvidia, Cisco, and the hyperscalers: transparent, audit-ready AI for the regulated economy. It is not the most click-friendly story, but it is one that generates recurring business from large enterprises with high switching costs.

IBM Technical Breakout: Trendline above 1.272 Fib at $237

IBM broke above a downtrend on the daily chart, crossing a trendline with a green candle and the 1.272 fib extension at $237.23 on high volume. The RSI is in bullish territory, with a positive divergence on its recent dip to 65.59. The 50- and 100-day MAs are trailing well below as the primary level of support.

IBM Price Chart - Source: Tradingview

Major resistance sits at $258.85 to $263.76, with $272.84 to $277.28 above. The first area of support is between $238.68 to $230.87 should the rally give way fully, followed by $214.80. The prior Fibonacci 0.618 to 0.786 retracement zone at $224 to $231 held perfectly before this breakout, indicating the formation of this level.

Trade Idea

Enter the long above $255, which will hold trendline resistance.

Target #1: $263.76, which is trend resistance

Target #2: $272.84-$277.28, which was the high in February as well as higher Fibonacci extension.

Stop loss: Daily close below $245, where trend resistance is no longer valid and a return to the range.

Why did IBM stock jump 12% on May 22?

IBM shares rose 12.43% Tuesday after the US Department of Commerce announced a proposed $1 billion CHIPS Act award for the country's first-purpose-built, IBM-led, quantum computing chip foundry. IBM said its proposed quantum foundry would enable the industry to accelerate development of fault-tolerant quantum computers, which are expected to launch by 2029. IBM also highlighted progress on its quantum computing roadmap, citing recent milestone research that simulated protein structures with relevance to drug discovery.

"The CHIPS Act award, which represents infrastructure capital and not research funding, designates IBM as the national champion quantum foundry, and could help accelerate our 2029 fault-tolerant timeline," IBM said. "IBM quantum systems already support commercial clients, and in March announced a milestone in research, successfully simulating protein structures that could have relevance to pharmaceutical drug discovery."

What is IBM’s quantum roadmap?

IBM is laying the foundation to launch its first large-scale, fault-tolerant quantum computer system by 2029. Fault-tolerant quantum computing will be able to self-correct computational errors in real time, allowing IBM and its commercial clients to run large-scale, dependable computations. This will be crucial for breakthroughs and improvements in fields like drug discovery, materials science, financial modeling, and cryptographic security.

The proposed $1 billion CHIPS Act quantum foundry would be a manufacturing site to produce IBM quantum chips and components at a commercial scale. IBM is already delivering IBM Quantum System One systems to clients, including those in the health-care sector that benefit from its ability to simulate complex biological molecules.

Is IBM a buy after today's 12% pop?

The technical chart shows a clean technical breakout for IBM shares on May 22. IBM cleared the descending trendline, 1.272 Fibonacci extension at $237.23 on high volume, and the RSI indicator at 65.59 is sitting in a healthy, bullish position.

A long trade above $255 targets price movement into $263.76 and $272.84 to $277.28, with a risk stop positioned below $245. Fundamentally, IBM reported better than expected $1.91 diluted EPS in the first quarter 2026 fiscal year, grew free cash flow by 13% to $2.2 billion in Q1, and is continuing to accelerate the adoption of its Red Hat software solutions in AI services. The CHIPS Act award for a quantum foundry also opens up the possibility for another near-term catalyst for the stock, as a government-funded infrastructure project.

IBM is hardly a "high growth" name in today's market environment, but its new-found position in the space of quantum computing, along with its reliable cash flow generation and a high and growing dividend, make IBM a relatively attractive risk/reward at these levels from an income and growth perspective.

Bottom line

A one-day 12% move is relatively uncommon historically in IBM's 130-plus year history, which warrants a second look at what's driving the stock. The $1 billion CHIPS Act quantum foundry announcement is a substantial deal, but it is not a research grant. It is government infrastructure capital, which signals IBM is not a speculative AI and quantum stock. The CHIPS Act award will support IBM's technical roadmap to launch its first fault-tolerant quantum system by 2029.

On top of that, IBM's Q1 fundamentals were robust, as the company delivered an EPS beat, accelerated the growth of its free cash flow, and continues to expand the adoption of its governed enterprise AI solutions from its Red Hat software solutions. IBM is not necessarily the most hyped AI name in the market. However, between its potential in the realm of quantum computing, its governance-enabled enterprise AI platform, and its strong free cash flow generation, it's potentially more of a sustainable one than most.